インドのジェネリック医薬品産業プロファイルでは、市場規模(2018〜2023年の値、および2028年までの予測)などのトップラインの定性的および定量的概要情報が提供されます。プロファイルには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths and strategies of the leading players?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. Sun Pharmaceutical Industries Ltd
8.2. Cipla Ltd
8.3. Aurobindo Pharma Ltd
8.4. Lupin Ltd
8.5. Dr. Reddy's Laboratories Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: India generics market value: $ million, 2018-23
Table 2: India generics market volume: % of total pharma volume, 2018-23
Table 3: India generics market geography segmentation: $ million, 2023
Table 4: India generics market value forecast: $ million, 2023-28
Table 5: India generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Sun Pharmaceutical Industries Ltd: key facts
Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
Table 9: Cipla Ltd: key facts
Table 10: Cipla Ltd: Annual Financial Ratios
Table 11: Cipla Ltd: Key Employees
Table 12: Aurobindo Pharma Ltd: key facts
Table 13: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 14: Aurobindo Pharma Ltd: Key Employees
Table 15: Lupin Ltd: key facts
Table 16: Lupin Ltd: Annual Financial Ratios
Table 17: Lupin Ltd: Key Employees
Table 18: Dr. Reddy's Laboratories Ltd: key facts
Table 19: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
Table 20: Dr. Reddy's Laboratories Ltd: Key Employees
Table 21: India Size of Population (million), 2019-23
Table 22: India Real GDP (Constant 2010 Prices, $ Billion), 2019-23
Table 23: India GDP (Current Prices, $ Billion), 2019-23
Table 24: India Inflation, 2019-23
Table 25: India Consumer Price Index (Absolute), 2019-23
Table 26: India Exchange Rate, 2018-23
List of Figures
Figure 1: India generics market value: $ million, 2018-23
Figure 2: India generics market volume: % of total pharma volume, 2018-23
Figure 3: India generics market geography segmentation: % share, by value, 2023
Figure 4: India generics market value forecast: $ million, 2023-28
Figure 5: India generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in India, 2023
Figure 7: Drivers of buyer power in the generics market in India, 2023
Figure 8: Drivers of supplier power in the generics market in India, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2023
Figure 11: Drivers of degree of rivalry in the generics market in India, 2023